Teleflex (NYSE:TFX) subsidiary NeoTract said today that the American Urological Association now recommends the use of NeoTract’s UroLift system as a standard of care treatment for lower urinary tract symptoms due to benign prostatic hyperplasia. The company’s UroLift system uses tiny devices inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside […]
Urology
Boston Scientific closes $400m NxThera buy
Boston Scientific (NYSE:BSX) said today that it closed the $406 million acquisition of NxThera and its Rezūm benign prostatic hyperplasia device, which uses steam to ablate excess prostate tissue. The deal called for $306 million in up-front cash from Marlborough, Mass.-based Boston Scientific, with another $100 million in potential milestones over the next four years. Boston, which in December 2015 led […]
Laborie Medical closes $214m Cogentix buy
Laborie Medical Technologies said today that it closed the $214 million acquisition of Cogentix Medical (NSDQ:CGNT). With about 85% of the urology and gynecology device maker’s shares tendered over the weekend, meeting the minimum tender requirement, the stage was set for the deal to close today. The $3.85-per-share cash tender pulled in some 51.5 million shares, for about $198.2 million, […]
FDA approves IDE trial for Urotronic’s drug-coated balloon
Minneapolis-based Urotronic said this week that the FDA approved an investigational device exemption trial for its Optilume drug-coated balloon catheter, which is designed to treat urethral strictures in men. The 200-patient pivotal trial is slated to start enrolling participants immediately. Get the full story at our sister site, Drug Delivery Business News.
Funding Roundup: Swiss Advanced Vision seeks $21m for auto-focus IOL
Funding Roundup A clutch of medical device companies raised cash to fund their operations, includingAscentX Medical, Avenda Health, Global Kinetics, Nephros, OrthoSensor and Swiss Advanced Vision. Here’s a look at them, their technologies and how much they drummed up. Next >>
7 medtech stories we missed this week: April 6, 2018
From CHF Solutions’s distribution deal to Guided Therapeutics’s licensing agreement, here are seven medtech stories we missed this week but throught were still worth mentioning. 1. CHF inks Spanish distribution deal CHF Solutions announced in an April 5 press release that it has signed a distribution agreement with Dimedix Surgical. The distribution agreement will allow […]
UPDATE: Boston Scientific lays out $406m for NxThera which plans spin-out of cancer treatment tech
Updated with comments from NxThera president & CEO Bob Paulson. Boston Scientific (NYSE:BSX) said today that it laid out a $406 million deal for NxThera and its Rezūm benign prostatic hyperplasia device, which uses steam to ablate excess prostate tissue. The deal calls for $306 million in up-front cash from Marlborough, Mass.-based Boston Scientific, with another $100 million in […]
Urology startup UroCure raises $3m
Urology device startup UroCure has raised $2.5 million as it looks to fund development of urethral slings designed to treat female stress urinary incontinence, president and CEO John Nealon told MassDevice.com in an interview. The Minnesota-based company is developing the devices based on technology it acquired from Endo International (NSDQ:ENDP) subsidiary American Medical Systems Holdings, Nealon said. “The […]
UroViu wins FDA nod for disposable diagnostic cytoscope
UroViu said yesterday it won FDA 510(k) clearance for its Uro-V single-use diagnostic cytoscopic system designed to visually assess the urethra and urinary bladder in instances of suspected pathology or dysfunction. The Bellevue, Wash.-based company’s newly cleared Uro-V device is a self-contained single-use diagnostic cytoscope designed for female diagnostic cytoscopy. The system is designed to […]
Laborie Medical to pay $214m for Cogentix
Laborie Medical Technologies said today that it agreed to pay $214 million for Cogentix Medical (NSDQ:CGNT) and its line of urology and gynecology devices. Formed by the 2015 merger of Vision-Sciences and Uroplasty, Minnetonka, Minn.-based Cogentix makes the Urgent PC neuromodulation device for treating overactive bladder syndrome, the PrsimeSight cystoscopy and EndoSheath devices and Macroplastique, an injectable soft-tissue bulking agent for […]
Spinal Singularity launches feasibility study for smart urinary catheter
Catheter developer Spinal Singularity said yesterday it launched a clinical feasibility trial of its Connected Catheter, a smart catheter designed for adult men with chronic urinary retention or neurogenic lower urinary tract dysfunction. The trial is being led by West Coast Urology co-founder Dr. Ernest Agatstein, the San Clemente, Calif.-based company said. “It has been amazing […]